July 1 (UPI) — Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced. The … Click to Continue »
View original article
Contributor:
July 1 (UPI) — Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the company announced. The … Click to Continue »
View original article
Contributor: